Document is current
Any future updates will be listed below
-
Authors
Lo, Siu Hing https://orcid.org/0000-0002-2952-150X
Marshall, Jade https://orcid.org/0000-0001-5632-3528
Skrobanski, Hanna https://orcid.org/0000-0003-0868-8914
Lloyd, Andrew https://orcid.org/0000-0002-7597-6556
-
Funding
Funding for this research was provided by:
gw pharmaceuticals, cambridge, uk
- License Information
-
More Information
Article History
Accepted: 27 July 2021
First Online: 15 September 2021
Declarations
:
: This study was funded by GW Pharmaceuticals, Cambridge, UK.
: SHL, AL and HS are employees of Acaster Lloyd Consulting Ltd. JM is an employee of GW Pharma Ltd.
: The sponsor is adhering to current US and EU requirements so will not make individual deidentified participant data available; however, the protocol and statistical analysis plan will be made available upon request to the corresponding author.
: Not applicable.
: This study was reviewed and received exempt status determination by the Western Institutional Review Board on 7 August 2020, prior to participant recruitment.
: Informed consent was obtained from all individual participants.
: Not applicable.
: All authors met the ICMJE authorship criteria and had full access to relevant data. Neither honoraria nor payments were made for authorship. All authors were involved in the conception and design of the study. SHL, AL, and HS conducted the study and analysed the data. All authors revised the paper critically for intellectual content before providing final approval of the version to be published. All authors agree to be accountable for all aspects of the work.
